Jul. 29 at 3:50 PM
$RFL BioTechnicity - The last raise was a
$25.0M rights offering that closed June 4, 2025, with a
$21.0M backstop from the Jonas family. Public subscriptions came to about
$4.0M. So Jonas funded roughly 84% of it himself. That's a hard fact to reconcile with a CEO managing an exit ahead of bad news. RFL closed
$2.28 on July 27, up 7%, against a 52-week range of
$1.12 to
$3.96 — it was
$3.78 on July 1 after a 176% month. You are calling it "pocket change" on a stock that roughly doubled off the lows.
